Osteoarthritis, genetic and molecular mechanisms

被引:44
作者
Peter Ghosh
Margaret Smith
机构
[1] Institute of Bone and Joint Research,
[2] (Department of Surgery,undefined
[3] University of Sydney) at the Royal North Shore Hospital,undefined
来源
Biogerontology | 2002年 / 3卷
关键词
cartilage; cytokines; nitric oxide radical; osteoarthritis; proteoglycans;
D O I
暂无
中图分类号
学科分类号
摘要
Osteoarthritis (OA) is the most common musculoskeletal disorder world-wide and has enormous social and economic consequences. OA is a multifactorial disorder in which ageing, genetic, hormonal and mechanical factors are all major contributors to its onset and progression. The primary lesion in OA would appear to occur in the articular cartilage (AC) which covers the weight-bearing surfaces of diarthrodial joints. Studies on AC have shown a decline in the chondrocyte numbers and their viability with ageing; largely due to nitric oxide radical mediated apoptosis. Since chondrocytes are responsible for the synthesis of the extensive extracellular matrix of AC, their decline in numbers limits the AC's ability to maintain homeostasis and thus functionality. Moreover, the chondrocytes remaining in the AC show diminished capacity to respond to growth factors which also restricts repair and their metabolism is greatly affected by cytokines and nitric oxide free radical produced during synovial inflammation and the imposition of supranormal mechanical stresses. Proteoglycans (PGs) provide the resilience of AC and a reduction in their synthesis, molecular size and increased catabolism in OA joints, marked lyimpairs AC capacity to efficiently respond to mechanical stress, leading to fibrillation and erosion down to subchondral bone. Recent OA research has sought to identify modalities which retard, or even reverse these pathological events. While many claims of disease modifying drugs in OA (DMOAD) have been made, our research has indicated that calcium pentosan polysulfate (CaPPS) exhibits considerable potential in this regard. CaPPS corrects many of the phenotypic imbalances (described above) in chondrocyte metabolism and promotes the synthesis of large PGs. Furthermore, it inhibits the enzymes responsible for PG and collagen degradation and increases the translation of tissue inhibitor of metalloproteinase-3 (TIMP-3) by synoviocytes and chondrocytes, thereby, reducing proteolytic and angiogenic activity within the joint space.
引用
收藏
页码:85 / 88
页数:3
相关论文
共 142 条
[1]
Abbaszade I(1999)Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family J Biol Chem 274 23443-23450
[2]
Liu R-Q(1993)Matrix metalloproteinases: a review Crit Rev Oral Biol Med 4 197-250
[3]
Yang F(1977)Histological and biochemical studies on cartilage from osteoarthrotic femoral heads with special reference to surface characteristics Connect Tissue Res 5 41-49
[4]
Rosenfeld SA(1997)Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation Nat Genet 17 439-444
[5]
Ross OH(1991)Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan-human specific repeats, and additional alternatively spliced forms Biol Chem 266 894-902
[6]
Link JR(1996)Nitric oxide and cartilage metabolism. Methods Enzymol 269: 75-88 Ghosh P (1999) The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment Semin Arthritis Rheum 28 211-267
[7]
Ellis DM(1998)Detection of COX-1 and COX-2 isoforms in synovial fluid cells from inflammatory joint diseases Br J Rheumatol 37 773-778
[8]
Tortorella MD(2000)Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis. Studies in a non-human primate model of naturally occurring disease Arthritis Rheum 43 2110-2120
[9]
Pratta MA(1992)Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures Biomaterials 13 67-97
[10]
Hollis JM(2000)Calcium pentosan polysulphate inhibits the catabolism of aggrecan in articular cartilage explant cultures Arthritis Rheum 43 2211-2218